Chenwei Wang
State Key Laboratory Of Oncology In South China
Guangzhou, China
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Posaconazole mitigates α-amanitin-induced liver injury by inhibiting STT3B-mediated glycosylation and cellular uptake.
Journal: Frontiers in pharmacology
Published: April 24, 2026
HSPA6 Confers Lenvatinib Resistance in Hepatocellular Carcinoma by Promoting Phase Separation-Mediated TXNRD1 Stabilization to Suppress Ferroptosis.
Journal: Cancer research
Published: January 20, 2026
Sintilimab and lenvatinib plus hepatic arterial infusion chemotherapy and embolization as conversion therapy for uHCC: A phase 2 trial.
Journal: Med (New York, N.Y.)
Published: October 14, 2025
COLEC12high tumor-associated macrophages orchestrate lenvatinib resistance and cancer stemness in hepatocellular carcinoma via paracrine NRG1-HER2/HER3 signaling.
Journal: Clinical and molecular hepatology
Published: September 26, 2025
Partial hepatectomy versus interventional treatment in patients with hepatitis B virus-related hepatocellular carcinoma and clinically significant portal hypertension: a randomized comparative clinical trial.
Journal: Cancer communications (London, England)
Published: April 02, 2024
Comprehensive analysis of m6A modification in immune infiltration, metabolism and drug resistance in hepatocellular carcinoma.
Journal: Cancer cell international
Published: August 09, 2023
Repeat hepatectomy versus percutaneous ablation for recurrent hepatocellular carcinoma: emphasis on the impact of early or late recurrence.
Journal: Journal of cancer research and clinical oncology
Published: July 13, 2023
Watch-and-wait strategy vs. resection in patients with radiologic complete response after conversion therapy for initially unresectable hepatocellular carcinoma: a propensity score-matching comparative study.
Journal: International journal of surgery (London, England)
Published: June 19, 2023
RFX6 facilitates aerobic glycolysis-mediated growth and metastasis of hepatocellular carcinoma through targeting PGAM1.
Journal: Clinical and translational medicine
Published: March 08, 2023
The apolipoprotein B and apolipoprotein A-I Ratio serves as a strong prognostic factor for the overall survival of patients with colorectal cancer.
Journal: Frontiers in oncology
Published: November 18, 2022
PRMT3-mediated arginine methylation of IGF2BP1 promotes oxaliplatin resistance in liver cancer.
Journal: Nature communications
Published: May 31, 2022
S100A9 Derived from Chemoembolization-Induced Hypoxia Governs Mitochondrial Function in Hepatocellular Carcinoma Progression.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: April 15, 2022
Last Updated: 09/26/2026